Last modified: 11 March 2014
Latest News
Myeloma Patients Europe
News: Myeloma Patients Europe Bulletin, Issue 2, February 2013
More ...
MPE - Breaking News
Patient and healthcare professional views differ on quality of life issues // Myeloma patients europe granted membership of Eurordis More ...
Myeloma Patients Europe
News: Myeloma Patients Europe Bulletin, Issue 1, Summer 2012
More ...
Patient Guide for Myeloma Bone Disease and Bisphosphonates
This brochure provides information on why myeloma bone disease occurs, how it is diagnosed and monitored and how it is managed and treated. More ...
Raising Awareness of Haematology at the European Parliament
EHA and ECPC (European Cancer Patient Coalition) together with patient advocates. More ...
Haematology and the next European Decade
A stakeholders meeting
30-31 August 2011, European Parliament, Brussels More ...
Myeloma Patients Europe
On Friday 21 October 2011, the European Myeloma Platform (EMP) and Myeloma Euronet (ME) merged to become Myeloma Patients Europe. More ...
Video Statement
New video: Statement from Anita Waldmann, President of Myeloma Euronet. More ...
Patient Guide for Stem Cell Mobilisation
This brochure is written to provide patients, their families and friends information on haematopoietic stem cell transplantation, and the use of Plerixafor in stem cell mobilisation.
More ...
The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab
Full text including high-resolution figures, can be found at The Oncologist!
More ...
Roundtable debate
Roundtable debate: accuracy in the media with ECCO’s Patient Advisory Committee.
One main goal of the eurocancercoms project is to evaluate information accessed by health professionals, patients, consumer groups and industry, as well as the credibility of different sources. More ...
Updated brochure on Bortezomib (Velcade®)
An updated brochure on Bortezomib (Velcade®) for myeloma patients, their families and friends is now available for download from this Web site. The brochure reviews what Velcade is, how it works, when it is used in multiple myeloma, what to expect from treatment and what potential side-effects may occur. More ...
Sitemap
Top of page